Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Syneron Medical Ltd.    ELOS   IL0010909351

Delayed Quote. Delayed  - 08/31 10:00:00 pm
6.56 USD   -2.96%
08/04 SYNERON MEDICAL : Reports Second Quarter 2016 Revenue of $75.0 Milli..
07/25 SYNERON MEDICAL : Candela's PicoWay Picosecond Laser Receives U.S. F..
07/18 SYNERON MEDICAL : to Report Second Quarter 2016 Financial Results on..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/25/2016 08/26/2016 08/29/2016 08/30/2016 08/31/2016 Date
6.5(c) 6.44(c) 6.63(c) 6.76(c) 6.56 Last
34 164 60 551 90 738 167 369 498 288 Volume
-1.52% -0.92% +2.95% +1.96% -2.96% Change
More quotes
Financials ($)
Sales 2016 293 M
EBIT 2016 13,3 M
Net income 2016 3,14 M
Debt 2016 -
Yield 2016 -
Sales 2017 313 M
EBIT 2017 19,0 M
Net income 2017 9,24 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 173,33
P/E ratio 2017 27,59
Capi. / Sales2016 0,80x
Capi. / Sales2017 0,75x
Capitalization 235 M
More Financials
Company
Syneron Medical Ltd. engages in the provision of aesthetic medical treatment.Its activities include design, development and marketing of aesthetic medical products using technologies such as Electro-Optical Synergy, a technology which uses the synergy between electrical energy, including... 
More about the company
Surperformance© ratings of Syneron Medical Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on SYNERON MEDICAL LTD.
08/04 SYNERON MEDICAL : Reports Second Quarter 2016 Revenue of $75.0 Million and Non-G..
07/25 SYNERON MEDICAL : Candela's PicoWay Picosecond Laser Receives U.S. FDA Clearance..
07/18 SYNERON MEDICAL : to Report Second Quarter 2016 Financial Results on August 4, 2..
05/19 SYNERON MEDICAL : Reports First Quarter 2016 Revenue of $68.7 Million
05/16SYNERON MEDICAL LTD. : quaterly earnings release
04/27 SYNERON MEDICAL : to Report First Quarter 2016 Financial Results on May 19, 2016
03/31 SYNERON MEDICAL : Candela Leads Energy Innovation Discussions at 36th Annual ASL..
03/21 SYNERON MEDICAL : Announces Availability of its Annual Report on Form 20-F throu..
03/05 SYNERON MEDICAL : and Allergan Announce U.S. Aesthetics Collaboration
03/03 SYNERON MEDICAL : Candela to Introduce New Technologies at the 2016 American Aca..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
08/27 ABBOTT LABORATORIES : Whiplashed investors stay skittish about St. Jude
08/26DJST JUDE MEDICAL : . Jude Denies Report Its Heart Devices Are Vulnerable to Cyber..
08/26DJST JUDE MEDICAL : . Jude Denies Report Its Heart Devices Are Vulnerable to Cyber..
08/26 MUDDY WATERS SAYS ST. JUDE SHARES CO : Cnbc
08/26DJST JUDE MEDICAL : . Jude Denies Claims in Muddy Waters Report
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
08/04 Syneron Medical's (ELOS) CEO Amit Meridor on Q2 2016 Results - Earnings Call ..
08/04 Syneron Medical beats by $0.03, misses on revenue
08/03 Notable earnings before Thursday?s open
07/28 Cynosure Still Looks Attractive After A Bull Run
07/18 FDA OKs Syneron's fat-busting UltraShape Power
Advertisement
Chart SYNERON MEDICAL LTD.
Duration : Period :
Syneron Medical Ltd. Technical Analysis Chart | ELOS | IL0010909351 | 4-Traders
Full-screen chart
Technical analysis trends SYNERON MEDICAL LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 11,2 $
Spread / Average Target 66%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Amit Meridor President & Chief Executive Officer
Shimon Eckhouse Chairman
Shlomo Alkalay Chief Operating Officer
Hugo Goldman Chief Financial Officer
Dan S. Suesskind Independent External Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SYNERON MEDICAL LTD.-12.32%235
MEDTRONIC PLC12.91%121 028
ZIMMER BIOMET HOLDINGS..26.59%25 976
BAXTER INTERNATIONAL I..22.91%25 503
C R BARD INC16.72%16 242
TERUMO CORP8.49%15 134
More Results